Bespoke Extracts Inc (BSPK)
0.0981
-0.01
(-10.78%)
USD |
OTCM |
May 03, 16:00
Bespoke Extracts Gross Profit Margin (Quarterly): 61.93% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 61.93% |
| September 30, 2023 | 40.26% |
| June 30, 2023 | 37.74% |
| March 31, 2023 | 11.63% |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -13.39K% |
| March 31, 2022 | 72.33% |
| November 30, 2021 | 50.71% |
| August 31, 2021 | 54.13% |
| May 31, 2021 | 68.51% |
| Date | Value |
|---|---|
| February 28, 2021 | 51.12% |
| November 30, 2020 | 72.85% |
| August 31, 2020 | 61.71% |
| May 31, 2020 | |
| February 29, 2020 | |
| November 30, 2019 | 37.49% |
| August 31, 2019 | -761.0% |
| May 31, 2019 | 26.47% |
| February 28, 2019 | 65.78% |
| November 30, 2018 | 71.98% |
| August 31, 2018 | -44.01% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-13.39K%
Minimum
Jun 2022
72.85%
Maximum
Nov 2020
-900.1%
Average
50.71%
Median
Nov 2021
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -355.0% |
| Profit Margin (Quarterly) | -102.0% |
| Operating Margin (Quarterly) | -100.4% |
| Return on Net Operating Assets | -365.6% |